Compare Enact Holdings Inc (ACT) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enact Holdings Inc vs Nomura Holdings Inc — how do they compare? Enact Holdings Inc trades at $49.44 (market cap $6.79B), while Nomura Holdings Inc trades at $9.89 (market cap $28.73B). The key difference: Nomura Holdings Inc is far larger — about 4.2× Enact Holdings Inc's market cap, and Nomura Holdings Inc pays the higher dividend (3.27%). Which is the better fit depends on your goals.
| ACT | NMR | |
|---|---|---|
Market Cap | $6.79B | $28.73B |
Sector | Technology | Financials |
52-Week High | $49.38 | $10.04 |
52-Week Low | $34.93 | $6.73 |
Enterprise Value | $7.09B | — |
Dividend Yield | 1.94% | 3.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACT trades at $49.38, up 1.81% today, with a bullish technical signal from moving averages but overbought RSI readings. The stock shows strong profitability with a net income margin of 54.51% and ROE of 12.87%, supported by recent earnings beats. Analysts have a consensus price target of $49.00, with 37.5% buy ratings. Recent news highlights Q2 2026 earnings beating estimates and dividend announcements.
The outlook is cautiously optimistic given solid fundamentals and positive earnings trends, but risks include potential overvaluation with a P/S of 5.65 and technical overbought conditions. Investor sentiment is mixed with no sell ratings, yet the stock faces execution risks in a competitive insurance market.
Nomura Holdings (NMR) trades at $9.925, up 1.07% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported strong revenue growth, with 2025 revenue reaching $1.66 trillion and net income of $340.74 billion, yielding a net margin of 20.4%. Recent earnings show a mix of beats and misses, with Q2 2026 EPS beating expectations. Analyst consensus leans toward Hold, with 66.67% of coverage recommending Hold and 33.33% Buy.
The outlook for NMR is supported by robust profitability and valuation metrics like a P/E of 11.59, suggesting potential undervaluation. However, risks include inconsistent cash flow from operations, rising debt-to-asset ratios, and macroeconomic sensitivity. Investors should weigh solid fundamentals against cash flow volatility and debt trends for balanced decision-making.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enact Holdings Inc
Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.
Read more on ACT →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
